4-(2-(2-hydroxycyclohexylamino)benzothiazol-6-yloxy)pyridine-2-carboxylic acid methylamide,
BLZ 945,
BLZ-945,
BLZ945,
BLZ945,
953769-46-5,
BLZ-945,
BLZ 945,
4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide,
UNII-7W3V82OQ0P,
7W3V82OQ0P,
4-((2-(((1R,2R)-2-Hydroxycyclohexyl)amino)benzo-[d]thiazol-6-yl)oxy)-N-methylpicolinamide,
GTPL8250,
SCHEMBL2676695,
EX-A817,
SYN1197,
ADZBMFGQQWPHMJ-RHSMWYFYSA-N,
4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide,
KS-00001D1X,
3193AH,
MFCD28142668,
s7725,
ZINC68203100,
AKOS025396391,
CS-3971,
SB18873,
NCGC00386432-02,
AS-16330,
BC600698,
HY-12768,
QC-11680,
J3.661.938D,
4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzo[d]thiazol-6-yloxy)-N-methylpicolinamide,
2-Pyridinecarboxamide, 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)-6-benzothiazolyl)oxy)-N-methyl-,
4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide,
N-Methyl-4-[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]benzothiazole-6-yloxy]pyridine-2-carboxamide,
D08NDE,
C20H22N4O3S,
CSF-1R inhibitor (bone cancer),
CSF-1R inhibitor (bone cancer), Novartis,
B4899,
A15540,
C568289,
4-(2-(2-hydroxycyclohexylamino)benzothiazol-6-yloxy)pyridine-2-carboxylic acid methylamide,